InsidersTradesSigma
Follow the LIPELLA PHARMACEUTICALS INC stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €152k. The latest transaction was filed on 27 December 2022 (J). Among the most active insiders: Chancellor Michael B. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
LIPELLA PHARMACEUTICALS INC 是一家专注于开发创新药物治疗的公司。该公司在纳斯达克上市，股票代码为 XNAS。